FAB LMB 96 -- TREATMENT OF MATURE B-CELL LYMPHOMA/LEUKAEMIA: A SFOP LMB 96/CCG 5961/UKCCSG NHL 9600 COOPERATIVE STUDY.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide (Primary) ; Cytarabine; Doxorubicin; Etoposide; Methotrexate; Prednisolone; Prednisone; Vincristine
- Indications B-cell lymphoma; Burkitt's lymphoma; Diffuse large B cell lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 24 Jul 2014 Biomarkers information updated
- 27 Mar 2012 Actual patient number changed from 657 to 848 as reported by ClinicalTrials.gov record (NCT00162656).
- 27 Mar 2012 Actual patient number changed from 657 to 848 as reported by ClinicalTrials.gov record (NCT00162656).